Haryana FDA Busts Spurious Medicine Factory At Barwala

Panchkula : The Haryana Food and Drug Administration (FDA) busted a spurious medicine factory in Barwala, Panchkula, here on Friday. The factory allegedly used to supply spurious medicines from Barwala to Delhi. It is suspected to be a big racket of counterfeit medicines at national level.

As per the information shared by an FDA spokesperson, the officials of the department had earlier received complaints that counterfeit products of a medicine factory, Relieve Pharmaceuticals of Chandpur, Una, Himachal Pradesh, are being made and sold, from the owner Sukesh Chandra.

Acting on the information, a team was constituted under the leadership of FDA’s Assistant State Drug Controller Ripon Mehta, along with Senior Drug Control Officer, Ambala, Sunil Dahiya and drug control officer, Panchkula.

The team raided Cubic Light Science Private Limited, located at Industrial Area, Barwala, Panchkula, during which the team found 320 mg and 100 mg tablets which were branded as K2 tablets and with active ingredients calcium citrate, vitamin K-27, zinc and magnesium. The cost of these medicines has been estimated at Rs 5,69,940.

The manufacturer’s name printed on these counterfeit medicines was of Relieve Pharmaceuticals. The fake consignment of counterfeit medicines is said to have come from Bawana, Delhi. Sukesh Chandra informed the FDA team that they do not have any factory or office in Barwala or Delhi.

The team collected the sample of the medicines from the spot for testing and has seized the rest of the goods in its possession for further legal action. No police complaint has been registered yet and no arrests have been made in the matter.

The Delhi Drugs Department has been informed so that the racket can be busted. In the last few days, this is the fifth factory found making fake medicines.

  • Related Posts

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad